Skip to main content
. 2025 Aug 25;15:31265. doi: 10.1038/s41598-025-17245-1

Table 1.

Results of phylogenetic and mutational analysis of HBV whole genome sequences isolated from HBsAg positive donor blood samples.

No. Genotype length HBV DNA (copies/3 µL) PreS1/PreS2/S protein Polymerase X protein precore/core protein accession No.
preS1 preS2 S deletion DRM core promoter precore core protein
T2 A2 3221 bp 4163982.8 – – – – – 1858T > C LC851032
T9 A1 3179 bp 147.4 S17_F25del G138_Y140del

sM1K***

sF20S

sR24K

sI68T

sC76Y

sF85C

sM103I

sI110L

sS113T

G17_T18del

S198_I206del

S321_F323del

– – – 1858T > C

cR152_D153del (2354_2359del)

cS183P(2441 C > A)

LC851033
T11 A2 3221 bp 248090469.2 – – – – – – – 1858T > C – LC851034
T12 A2 3221 bp 20 – – – – – – – – – LC851035
T24 A2 3221 bp 1517.4 – – – – – – – 1858T > C – LC851036
T26 A2 3176 bp 47.3 –

N123_R137del

F141L

sF20S

sS167L

sL216*

V304_S318del – H94Y 1653 C > T – cS183P (2441 C > A) LC851037
T32 A2 3221 bp 102.4 – – – – – – –

eM1*(1814 A > C)*

1858T > C

1862G > T

LC851038
T5 B1 3215 bp 115.8 – – – – – I127M 1754T > G eW28* (1896G > A)*

2002 C > T

cS181P (2441T > C)

LC851443
T6 B2 3215 bp 151 W4P –

sL21S

sM133L

sY161F

– – I127V 1752 A > G eW28* (1896G > A)*

1915 C > G

cI97L (2189 A > C)

LC851444
T7 B1 3215 bp 63 – – sA159V – rtA194T I127T 1753T > G –

2002 C > T

cS181P (2441T > C)

LC851445
T8 B1 3215 bp 101.1 – –

sL21S

sG145A

– – I127M

1754T > G

1613G > A

eW28* (1896G > A)*

2002 C > T

cS181P (2441T > C)

LC851446
T15 B1 3215 bp 158.6 – – – – – – – 1858T > C

2002 C > T

cS181P (2441T > C)

LC851447
T18 B1 3215 bp 367744.3 – – sC76Y – – I127M 1754T > G eW28* (1896G > A)*

2002 C > T

cS181P (2441T > C)

LC851448
T21 B2 3215 bp 14.9 – – sL95W – – K130M/V131I 1762 A > T/1764G > A 1858T > C

1915T > G

cI97F (2189 A > T)

LC851449
T25 B1 3215 bp 97.9 – – sT126A – – – – eW28* (1896G > A)*

2002 C > T

cS181P (2441T > C)

LC851450
T33 B4 3215 bp 89.6 – – sK122R – – – – eG29D (1899G > A)

1915 C > G

cI97L (2189 A > C)

LC851451
T1 C2 3215 bp 1.2 – –

sLI68T

sL95W

– –

I127N

K130M/V131I

1674T > C

1753T > A

1762 A > T/1764G > A

– – LC852214
T4 C2 3215 bp 363754086.6 – – – – – – – – – LC852215
T10 C2 3215 bp 50.5 – –

sF20S

sV96A

sL98V

sI126S

– – – 1613G > A –

cI97L (2189 A > C)

cQ182* (2444 C > T*)

LC852216
T14 C2 3215 bp 4113.4 – –

sF20S

sL77R

– – K130M/V131I 1762 A > T/1764G > A eG29D (1899G > A)

1915G > A

cI97L (2189 A > C)

cL100I (2198 C > A)

LC852217
T16 C2 3215 bp 410.9 – – – – –

H94Y

K130M/V131I

1653 C > T

1762 A > T/1764G > A

eW28* (1896G > A)* cL60V(2078 C > G) LC852218
T17 C2 3215 bp 57.9 H51Q – sV96A – – – – –

2159 A > G

cI97L (2189 A > C)

LC852219
T19 C2 3215 bp 382.8 – – sF80S

H94Y

K130M/V131I

1653 C > T

1762 A > T/1764G > A

– – LC852220
T20 C2 3215 bp 222784834.2 – – – – – K130M/V131I 1762 A > T/1764G > A – – LC852221
T22 C2 3155 bp 192.8 –

M1del

S124_P142del

sI68T G299_G318del – – – –

2002 C > A

cI97F (2189 A > T)

LC852222
T23 C2 3215 bp 7614.1 – – sF20S – –

I127S

K130M/V131I

1753T > G

1762 A > T/1764G > A

eW28* (1896G > A)* – LC852223
T27 C2 3215 bp 61739067.4 – – – – – – – – 2002 C > A LC852224
T28 C2 3215 bp 532 H51Q – sI68T – –

I127T

K130M/V131I

1753T > C

1762 A > T/1764G > A

–

2159 A > G

cI97L (2189 A > C)

LC852225
T30 C2 3215 bp 130.1 – – – – – – 1766 C > G – – LC852226
T31 C2 3182 bp 463,650 –

M120I ***

L131_P142del

– A312_S322del – – – eW28* (1896G > A)* cS181P (2441T > C) LC852227
T34 C2 3215 bp 184.3 – – – – – V131I

1764G > A

1766 C > T

– cI97L (2189 A > C) LC852228
T29 D2 3182 bp 493.3 – –

sV118T

sT127P

sV128A

– – I127L

1752 A > C

1766 C > G

– 1915T > A LC852229
T3 A 217 bp 8.1 N/A N/A sS167L N/A N/A N/A N/A N/A N/A LC867244

***Start codon mutation.

DRM: drug-resistant mutation, VEM: vaccine-escape mutation, N/A: not applicable.